Wound botulism complicating internal fixation of a complex radial fracture

Journal of Clinical Microbiology

Volumn 48, Issue 2, 2010, Pages 650-653

  Taylor, Steve M ^a   Wolfe, Cameron R ^a   Dixon, Terry C ^a   Ruch, David S ^a   Cox, Gary M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BOTULINUM ANTISERUM; CEFALEXIN; CEFAZOLIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ARTICLE; BONE RADIOGRAPHY; BOTULISM; CASE REPORT; CLOSTRIDIUM BOTULINUM; DEBRIDEMENT; DIPLOPIA; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHAGIA; ELECTROMYOGRAPHY; HUMAN; MALE; NERVE CONDUCTION; NUCLEOTIDE SEQUENCE; OSTEOMYELITIS; PHYSICAL EXAMINATION; PLATE FIXATION; PRIORITY JOURNAL; PTOSIS; RADIUS FRACTURE; SLURRED SPEECH;

ADULT; ANTI-BACTERIAL AGENTS; BOTULINUM ANTITOXIN; BOTULISM; CLOSTRIDIUM; FRACTURES, BONE; FRACTURES, OPEN; HUMANS; MALE; OSTEOMYELITIS; PROSTHESIS-RELATED INFECTIONS; WOUND INFECTION;

CLOSTRIDIUM ARGENTINENSE;

EID: 75649097130     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01258-09     Document Type: Article

References (16)

1. Campbell, K., M. D. Collins, and A. K. East. 1993. Nucleotide sequence of the gene coding for Clostridium botulinum (Clostridium argentinense) type G neurotoxin: genealogical comparison with other clostridial neurotoxins. Biochim. Biophys. Acta 1216:487-491.
2. Centers for Disease Control and Prevention. Botulism in the United States, 1899-1996: handbook for epidemiologists, clinicians, and laboratory workers. Centers for Disease Control and Prevention, Atlanta, GA.
3. Ciccarelli, A. S., D. N. Whaley, L. M. McCroskey, D. F. Gimenez, V. R. Dowell, Jr., and C. L. Hatheway. 1977. Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin. Appl. Environ. Microbiol. 34:843-848.
4. Franciosa, G., J. L. Ferreira, and C. L. Hatheway. 1994. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J. Clin. Microbiol. 32:1911-1917.
5. Giménez, D. F., and A. S. Ciccarelli. 1970. Another type of Clostridium botulinum. Zentralbl. Bakteriol. Orig. 215:221-224. (In German.)
6. Hatheway, C. H., J. D. Snyder, J. E. Seals, T. A. Edell, and G. E. Lewis, Jr. 1984. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J. Infect. Dis. 150:407-412.
7. Jankovic, J., and K. Schwartz. 1995. Response and immunoresistance to botulinum toxin injections. Neurology 45:1743-1746.
8. Simmon, K. E., L. Hall, C. W. Woods, F. Marco, J. M. Miro, C. Cabell, B. Hoen, M. Marin, R. Utili, E. Giannitsioti, T. Doco-Lecompte, S. Bradley, S. Mirrett, A. Tambic, S. Ryan, D. Gordon, P. Jones, T. Korman, D. Wray, L. B. Reller, M. F. Tripodi, P. Plesiat, A. J. Morris, S. Lang, D. R. Murdoch, and C. A. Petti. 2008. Phylogenetic analysis of viridans group streptococci causing endocarditis. J. Clin. Microbiol. 46:3087-3090.
9. Sonnabend, O., W. Sonnabend, R. Heinzle, T. Sigrist, R. Dirnhofer, and U. Krech. 1981. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J. Infect. Dis. 143:22-27.
10. Sonnabend, W. F., U. P. Sonnabend, and T. Krech. 1987. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme. Appl. Environ. Microbiol. 53:1880-1884.
11. Stevens, D. L., A. E. Bryant, and S. P. Hackett. 1995. Antibiotic effects on bacterial viability, toxin production, and host response. Clin. Infect. Dis. 20(Suppl. 2):S154-157.
12. Stevens, D. L., K. A. Maier, and J. E. Mitten. 1987. Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob. Agents Chemother. 31:213-218.
13. Suen, J., C. Hatheway, A. Steigerwalt, and D. Brenner. 1988. Clostridium argentinense sp. nov.: a genetically homogeneous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified as Clostridium subterminale or Clostridium hastiforme. Int. J. Syst. Bacteriol. 38:375-381.
14. Swenson, J. M., C. Thornsberry, L. M. McCroskey, C. L. Hatheway, and V. R. Dowell. 1980. Susceptibility of Clostridium botulinum to thirteen antimicrobial agents. Antimicrob. Agents Chemother. 18:13-19.
15. Tyler, H. R. 1963. Botulism. Arch. Neurol. 9:9.
16. Werner, S. B., D. Passaro, J. McGee, R. Schechter, and D. J. Vugia. 2000. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin. Infect. Dis. 31:1018-1024.